Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female, 2 months to \< 18 years old.~* Presence of CABP requiring hospitalization and IV antibacterial therapy~Exclusion Criteria:~* Documented history of any hypersensitivity of allergic reaction to any β-lactam antimicrobial.~* Confirmed or suspected infection with a pathogen known to be resistant to ceftriaxone.~* Confirmed or suspected respiratory tract infection attributed to sources other than CABP pathogens.~* Non-infectious causes of pulmonary infiltrates.

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Ceftaroline fosamil (Type: EXPERIMENTAL): None
- Ceftriaxone (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).